1-Benzyl-4-(hydroxymethyl)piperidin-4-ol, 97.0%, 1g

1-(2-Hydroxy-5-(trifluoromethyl)phenyl)ethanone, 95.0%, 2.5g

4-(4-methoxyphenyl)-1,3-dimethyl-1H-pyrazol-5-amine, 95.0%, 1g

2-(Trifluoromethyl)imidazo[1,2-a]pyridine, 95.0%, 250mg

Phenyl(2-thioxothiazolidin-3-yl)methanone, 97%, 1g

1-(4-Bromobenzyloxy)-2,5-difluorobenzene, 98.0%, 25g

5-Bromo-3-cyanoindole, 95.0%, 10g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

(4-((3-Methoxypropoxy)methyl)phenyl)boronic acid, 97%, 250mg

tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate, 95.0%, 250mg

1-(5-FLUOROPYRIMIDIN-2-YL)ETHANAMINE HCL, 95.0%, 250mg

2,5-Dichloronicotinamide, 97.0%, 25g

Sodium sulfite, min. 98%, anhydrous, 10 kg, plastic packaging.